OCUL Market Cap History



Below is a table of the OCUL market cap history going back to 7/25/2014:

Date OCUL Market Cap
7/25/2014270.49M
8/25/2014338.98M
11/3/2014328.15M
3/13/2015919.82M
5/3/2015471.24M
7/31/2015570.78M
10/31/2015213.46M
3/1/2016200.97M
8/1/2016108.72M
11/1/2016142.81M
3/1/2017251.34M
5/1/2017271.99M
8/1/2017187.71M
11/1/2017165.73M
3/1/2018205.40M
5/1/2018240.83M
8/1/2018215.34M
11/1/2018211.64M
3/1/2019200.05M
5/1/2019159.78M
8/5/2019220.88M
7/26/2019179.03M
11/7/2019158.18M
3/2/2020246.59M
5/1/2020306.84M
3/1/20211.48B
8/4/2021804.89M
11/3/2021550.06M
2/24/2022405.26M
5/6/2022266.36M
8/5/2022381.76M
11/4/2022269.54M
5/4/2023472.13M
8/3/2023350.09M
11/3/2023258.90M
3/6/20241.61B

Also see: OCUL Shares Outstanding History
and OCUL YTD Return
OCUL Historical Market Cap:
+20.37% CAGR
OCUL Historical Market Cap: +20.37% CAGR

Mouse over chart for data details
7/25/2014 ...3/6/2024
Ocular Therapeutix is a biopharmaceutical company. Co. commercializes two products in the U.S.: DEXTENZA®, an intracanalicular insert for the treatment of both post-surgical ocular inflammation and pain and ocular itching associated with allergic conjunctivitis, and ReSure Sealant, an ophthalmic device designed to prevent wound leaks in corneal incisions following cataract surgery. Co. also has product candidates in preclinical and clinical development designed to utilize its bioresorbable hydrogel technology to treat retinal diseases including wet age-related macular degeneration; glaucoma and ocular hypertension; and ocular surface diseases and conditions including dry eye disease. We show 36 historical shares outstanding datapoints in our OCUL shares outstanding history coverage, used to compute OCUL market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing OCUL market cap history over the course of time is important for investors interested in comparing OCUL's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of OCUL versus a peer is one thing; comparing OCUL market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like OCUL can fluctuate over the course of history. With this page we aim to empower investors researching OCUL by allowing them to research the OCUL market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree OCUL Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Ocular Therapeutix (OCUL) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

OCUP Market Cap History
OCX Market Cap History
ODT Market Cap History
OFIX Market Cap History
OGN Market Cap History
OHRP Market Cap History
OLMA Market Cap History
OM Market Cap History
OMED Market Cap History
OMER Market Cap History
More Healthcare companies »

 

OCUL Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.